Triptolide and its prodrug Minnelide target high-risk MYC-amplified medulloblastoma in preclinical models.

Autor: Rodriguez-Blanco, Jezabel1,2, Salvador, April D.1,2, Suter, Robert K.1,2, Swiderska-Syn, Marzena1,2, Palomo-Caturla, Isabel1,2, Kliebe, Valentin1,2, Shahani, Pritika1,2, Peterson, Kendell1,2, Turos-Cabal, Maria1,2, Vieira, Megan E.1,2, Wynn, Daniel T.1,2, Howell, Ashley J.1,2, Yang, Fan1,2, Ban, Yuguang1,2, McCrea, Heather J.1,2, Zindy, Frederique1,2, Danis, Etienne1,2, Vibhakar, Rajeev1,2, Jermakowicz, Anna1,2, Martin, Vanesa1,2
Zdroj: Journal of Clinical Investigation. 8/1/2024, Vol. 134 Issue 15, p1-17. 17p.
Databáze: Academic Search Ultimate